Pharming Group N.V. Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method
Pharming Group N.V. (PHAR) reported Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method of $623.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod · last filed 2026-04-02
EUR
| Period end | Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method 12 month |
|---|---|
| 2020-12-31 | 317.00K EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 229.00K EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-04-07 |
USD
| Period end | Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method 12 month |
|---|---|
| 2025-12-31 | $623.00K 20-F · filed 2026-04-02 |
| 2024-12-31 | -$1.76M 20-F · filed 2026-04-02 |
| 2023-12-31 | -$289.00K 20-F · filed 2026-04-02 |
| 2022-12-31 | -$1.08M 20-F · filed 2025-04-03 |
| 2021-12-31 | $694.00K 20-F · filed 2024-04-04 |
| 2020-12-31 | $362.00K 20-F · filed 2023-04-05 |
| 2019-12-31 | $257.00K 20-F · filed 2022-04-06 |